No plan to manufacture Covid-19 vaccine in India during pandemic: Pfizer

Company was the first vaccine maker to apply for an emergency-use authorisation in India.

Pharmaceutical company Pfizer on Thursday said it did not plan to manufacture its Covid-19 vaccine in its India during the pandemic, keeping its supply lines limited to the US and Europe.

Media reports on Wednesday said that Pfizer, an American company, had told the Indian government it would produce the vaccine locally if it got faster regulatory clearance and freedom on pricing and exports.

“Pfizer has created two dedicated supply lines with established vaccine capabilities – one each in the US and Europe – to exclusively manufacture this vaccine for use across the world. This will continue to be the company’s strategy